USFDA conducts GMP inspection of Sun Pharma’s Halol facility

14 Jun 2025 Evaluate

US Food and Drug Administration (USFDA) has conducted a Good Manufacturing Practices (GMP) inspection of Sun Pharmaceutical Industries’ Halol facility (Gujarat, India) from June 2, 2025 to June 13, 2025. At the conclusion of the inspection, the USFDA issued a Form-483, with 8 observations.

Sun Pharmaceutical Industries is the world's fourth largest specialty generic pharmaceutical company and India's top pharmaceutical company.


Sun Pharma Inds. Share Price

1622.30 9.75 (0.60%)
22-Jan-2026 12:17 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1622.30
Dr. Reddys Lab 1222.90
Cipla 1378.60
Zydus Lifesciences 883.75
Lupin 2174.50
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×